Morphine and fentanyl exposure during therapeutic hypothermia does not impair neurodevelopment

<p><strong>Background</strong></p> Hypothermia-treated and intubated infants with moderate or severe hypoxic-ischemic encephalopathy (HIE) usually receive morphine for sedation and analgesia (SA) during therapeutic hypothermia (TH) and endotracheal ventilation. Altered drug p...

Full description

Bibliographic Details
Main Authors: Gundersen, JK, Chakkarapani, E, Jary, S, Menassa, DA, Scull-Brown, E, Frymoyer, A, Walløe, L, Thoresen, M
Format: Journal article
Language:English
Published: Elsevier 2021
_version_ 1797098622746099712
author Gundersen, JK
Chakkarapani, E
Jary, S
Menassa, DA
Scull-Brown, E
Frymoyer, A
Walløe, L
Thoresen, M
author_facet Gundersen, JK
Chakkarapani, E
Jary, S
Menassa, DA
Scull-Brown, E
Frymoyer, A
Walløe, L
Thoresen, M
author_sort Gundersen, JK
collection OXFORD
description <p><strong>Background</strong></p> Hypothermia-treated and intubated infants with moderate or severe hypoxic-ischemic encephalopathy (HIE) usually receive morphine for sedation and analgesia (SA) during therapeutic hypothermia (TH) and endotracheal ventilation. Altered drug pharmacokinetics in this population increases the risk of drug accumulation. Opioids are neurotoxic in preterm infants. In term infants undergoing TH, the long-term effects of morphine exposure are unknown. We examined the effect of opioid administration during TH on neurodevelopmental outcome and time to extubation after sedation ended. <p><strong>Methods</strong></p> In this prospectively collected population-based cohort of 282 infants with HIE treated with TH (2007–2017), the cumulative opioid dose of morphine and equipotent fentanyl (10–60 µg/kg/h) administered during the first week of life was calculated. Clinical outcomes and concomitant medications were also collected. Of 258 survivors, 229 underwent Bayley-3 neurodevelopmental assessments of cognition, language and motor function at 18–24 months. Multivariate stepwise linear regression analysis was used to examine the relation between cumulative opioid dose and Bayley-3 scores. Three severity-groups (mild-moderate-severe) were stratified by early (<6 h) amplitude-integrated electroencephalography (aEEG) patterns. <p><strong>Findings</strong></p> The cumulative dose of opioid administered as SA during TH was median (IQR) 2121 µg/kg (1343, 2741). Time to extubation was independent of SA dose (p > 0.2). There was no significant association between cumulative SA dose and any of the Bayley-3 domains when analysing the entire cohort or any of the aEEG severity groups. <p><strong>Interpretation</strong></p> Higher cumulative opioid doses in TH-treated infants with HIE was not associated with worse Bayley-3 scores at 18–24 months of age. <p><strong>Funding</strong></p> The Bristol cooling program was funded by the Children's Medical Research Charity SPARKS managing donations for our research from the UK and US, the UK Moulton Foundation, the Lærdal Foundation for Acute Medicine in Norway and the Norwegian Research Council (JKG).
first_indexed 2024-03-07T05:12:16Z
format Journal article
id oxford-uuid:dbf5f0db-0fe8-4e44-8ca8-2df5e88a401c
institution University of Oxford
language English
last_indexed 2024-03-07T05:12:16Z
publishDate 2021
publisher Elsevier
record_format dspace
spelling oxford-uuid:dbf5f0db-0fe8-4e44-8ca8-2df5e88a401c2022-03-27T09:14:28ZMorphine and fentanyl exposure during therapeutic hypothermia does not impair neurodevelopmentJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:dbf5f0db-0fe8-4e44-8ca8-2df5e88a401cEnglishSymplectic ElementsElsevier2021Gundersen, JKChakkarapani, EJary, SMenassa, DAScull-Brown, EFrymoyer, AWalløe, LThoresen, M<p><strong>Background</strong></p> Hypothermia-treated and intubated infants with moderate or severe hypoxic-ischemic encephalopathy (HIE) usually receive morphine for sedation and analgesia (SA) during therapeutic hypothermia (TH) and endotracheal ventilation. Altered drug pharmacokinetics in this population increases the risk of drug accumulation. Opioids are neurotoxic in preterm infants. In term infants undergoing TH, the long-term effects of morphine exposure are unknown. We examined the effect of opioid administration during TH on neurodevelopmental outcome and time to extubation after sedation ended. <p><strong>Methods</strong></p> In this prospectively collected population-based cohort of 282 infants with HIE treated with TH (2007–2017), the cumulative opioid dose of morphine and equipotent fentanyl (10–60 µg/kg/h) administered during the first week of life was calculated. Clinical outcomes and concomitant medications were also collected. Of 258 survivors, 229 underwent Bayley-3 neurodevelopmental assessments of cognition, language and motor function at 18–24 months. Multivariate stepwise linear regression analysis was used to examine the relation between cumulative opioid dose and Bayley-3 scores. Three severity-groups (mild-moderate-severe) were stratified by early (<6 h) amplitude-integrated electroencephalography (aEEG) patterns. <p><strong>Findings</strong></p> The cumulative dose of opioid administered as SA during TH was median (IQR) 2121 µg/kg (1343, 2741). Time to extubation was independent of SA dose (p > 0.2). There was no significant association between cumulative SA dose and any of the Bayley-3 domains when analysing the entire cohort or any of the aEEG severity groups. <p><strong>Interpretation</strong></p> Higher cumulative opioid doses in TH-treated infants with HIE was not associated with worse Bayley-3 scores at 18–24 months of age. <p><strong>Funding</strong></p> The Bristol cooling program was funded by the Children's Medical Research Charity SPARKS managing donations for our research from the UK and US, the UK Moulton Foundation, the Lærdal Foundation for Acute Medicine in Norway and the Norwegian Research Council (JKG).
spellingShingle Gundersen, JK
Chakkarapani, E
Jary, S
Menassa, DA
Scull-Brown, E
Frymoyer, A
Walløe, L
Thoresen, M
Morphine and fentanyl exposure during therapeutic hypothermia does not impair neurodevelopment
title Morphine and fentanyl exposure during therapeutic hypothermia does not impair neurodevelopment
title_full Morphine and fentanyl exposure during therapeutic hypothermia does not impair neurodevelopment
title_fullStr Morphine and fentanyl exposure during therapeutic hypothermia does not impair neurodevelopment
title_full_unstemmed Morphine and fentanyl exposure during therapeutic hypothermia does not impair neurodevelopment
title_short Morphine and fentanyl exposure during therapeutic hypothermia does not impair neurodevelopment
title_sort morphine and fentanyl exposure during therapeutic hypothermia does not impair neurodevelopment
work_keys_str_mv AT gundersenjk morphineandfentanylexposureduringtherapeutichypothermiadoesnotimpairneurodevelopment
AT chakkarapanie morphineandfentanylexposureduringtherapeutichypothermiadoesnotimpairneurodevelopment
AT jarys morphineandfentanylexposureduringtherapeutichypothermiadoesnotimpairneurodevelopment
AT menassada morphineandfentanylexposureduringtherapeutichypothermiadoesnotimpairneurodevelopment
AT scullbrowne morphineandfentanylexposureduringtherapeutichypothermiadoesnotimpairneurodevelopment
AT frymoyera morphineandfentanylexposureduringtherapeutichypothermiadoesnotimpairneurodevelopment
AT walløel morphineandfentanylexposureduringtherapeutichypothermiadoesnotimpairneurodevelopment
AT thoresenm morphineandfentanylexposureduringtherapeutichypothermiadoesnotimpairneurodevelopment